IL-6-independent expression of Mcl-1 in human multiple myeloma

被引:36
|
作者
Zhang, B [1 ]
Potyagaylo, V [1 ]
Fenton, RG [1 ]
机构
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
关键词
Mcl-1; apoptosis; multiple myeloma; gene expression; IL-6;
D O I
10.1038/sj.onc.1206358
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mcl-1 is a critical antiapoptotic survival factor for human multiple myeloma (MM). We examined the importance of IL-6 for Mcl-1 expression in five MM cell lines and in primary MM cells from 14 patients. While culture of MM.1S cells in IL-6 did induce Mcl-1 expression, four other MM cell lines exhibited high levels of Mcl-1 expression that were unaffected by IL-6. Similarly, Mcl-1 expression in 10 of 14 primary MM isolates was found to be IL-6-independent. An analysis of the mechanisms responsible for IL-6-independent Mcl-1 expression was undertaken. ERK1/2 activity did not influence Mcl-1 expression, distinct from Mcl-1 regulation that occurs during myeloid differentiation from hematopoietic progenitor cells. Inhibition of the PI3K pathway led to growth inhibition of 8226 and ANBL-6 cells without reduction of Mcl-1 levels, and high level Mcl-1 expression was maintained in the absence of activated STAT3. Analysis of the transcriptional activity of 5-regulatory sequences from the human Mcl-1 gene in MM cells demonstrated high levels of IL-6-independent indicator gene activation as predicted. These data demonstrate that the mechanisms regulating Mcl-1 levels in MM cells are heterogeneous, and are often independent from IL-6 signaling pathways.
引用
收藏
页码:1848 / 1859
页数:12
相关论文
共 50 条
  • [1] IL-6-independent expression of Mcl-1 in human multiple myeloma
    Bin Zhang
    Valeria Potyagaylo
    Robert G Fenton
    Oncogene, 2003, 22 : 1848 - 1859
  • [2] The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-6)-dependent and IL-6-independent human multiple myeloma cell lines
    Georgii-Hemming, P
    Strömberg, T
    Janson, ET
    Stridsberg, M
    Wiklund, HJ
    Nilsson, K
    BLOOD, 1999, 93 (05) : 1724 - 1731
  • [3] INCREASING FREQUENCY OF MCL-1 mRNA EXPRESSION THROUGH THE STAGES OF MULTIPLE MYELOMA
    Mylin, A. K.
    Rasmussen, T.
    Lodahl, M.
    Dahl, I. M.
    Knudsen, L. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 81 - 81
  • [4] Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
    Al-Odat, O. S.
    von Suskil, M.
    Chitren, R. J.
    Elbezanti, W. O.
    Srivastava, S. K.
    Budak-Alpddogan, T.
    Jonnalagadda, S. C.
    Aggarwal, B. B.
    Pandey, M. K.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
    Al-Odat, Omar
    von Suskil, Max
    Chitren, Robert
    Elbezanti, Weam
    Srivastava, Sandeep
    Budak-Alpddogan, Tulin
    Jonnalagadda, Subash
    Aggarwal, Bharat
    Pandey, Manoj
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Mcl-1 regulation and its role in multiple myeloma
    Le Gouill, S
    Podar, K
    Harousseau, JL
    Anderson, KC
    CELL CYCLE, 2004, 3 (10) : 1259 - 1262
  • [7] Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells
    Puthier, D
    Derenne, S
    Barillé, S
    Moreau, P
    Harousseau, JL
    Bataille, R
    Amiot, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (02) : 392 - 395
  • [8] A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells
    Jourdan, M
    Veyrune, JL
    De Vos, J
    Redal, N
    Couderc, G
    Klein, B
    ONCOGENE, 2003, 22 (19) : 2950 - 2959
  • [9] A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells
    Michel Jourdan
    Jean-Luc Veyrune
    John De Vos
    Nicole Redal
    Guilhem Couderc
    Bernard Klein
    Oncogene, 2003, 22 : 2950 - 2959
  • [10] Glutamine Catabolism Maintains MCL-1 Expression in Glucose-Deprived Multiple Myeloma
    Wei, Changyong
    Bajpai, Richa
    Hunter, Alisha D.
    Mahboubi, Darius
    Shanmugam, Mala
    BLOOD, 2017, 130